Search results
Your search for ���������������������������������:kn39��������� ������ ������ ������ returned no results
Showing 181 to 195 of 814 results for ���������������������������������:know��������� ������ ������ ������
Showing 181 to 195 of 814 results for ���������������������������������:know��������� ������ ������ ������
This guideline covers good practice for developing and updating local formularies in line with statutory requirements. It supports developing formularies that reflect local needs, reduce variation in prescribing, and allow rapid adoption of new medicines and treatments.
This guideline covers assessing and managing non-complex fractures that can be treated in the emergency department or orthopaedic clinic. It aims to improve practice so that people with fractures receive the care that they need without unnecessary tests and treatments.
View recommendations for NG38Show all sections
Preventing suicide in community and custodial settings (NG105)
This guideline covers ways to reduce suicide and help people bereaved or affected by suicides. It aims to:
Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma (TA695)
Evidence-based recommendations on carfilzomib (Kyprolis) with dexamethasone and lenalidomide (Revlimid) for previously treated multiple myeloma in adults.
people who provide learning disability services during transition need to know and do to ensure a smooth transition. The Framework will...
Therapy Stroke Groups: Improving patient activity on the Stroke unit and efficiency of the workforce
Therefore we introduced a set time for the groups. This allowed ward staff to know the groups were taking place on a daily basis, so...
Onasemnogene abeparvovec for treating spinal muscular atrophy (HST15)
Evidence-based recommendations on onasemnogene abeparvovec (Zolgensma) for treating spinal muscular atrophy in babies.
Diroximel fumarate for treating relapsing–remitting multiple sclerosis (TA794)
Evidence-based recommendations on diroximel fumarate (Vumerity) for active relapsing–remitting multiple sclerosis in adults.
Evidence-based recommendations on brolucizumab (Beovu) for diabetic macular oedema in adults.
Risankizumab for treating moderate to severe plaque psoriasis (TA596)
Evidence-based recommendations on risankizumab (Skyrizi) for treating moderate to severe plaque psoriasis in adults.
Tofacitinib for treating juvenile idiopathic arthritis (TA735)
Evidence-based recommendations on tofacitinib for treating juvenile idiopathic arthritis.
Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine (TA535)
Evidence-based recommendations on lenvatinib (Lenvima) and sorafenib (Nexavar) for progressive, locally advanced or metastatic differentiated thyroid cancer in adults who have had radioactive iodine.
An advisory service from the UK’s National Institute for Health and Care Excellence to help other countries improve their nation’s health and wellbeing
rheumatologists… I had MRIs, X-rays, blood tests… If I knew then, what I know now about axial spondyloarthritis, I'd have known straight...
LTBEx – a new model for management of TB incidents in metropolitan areas
it offers screening in a familiar environment with support from those they know and trust. How did you implement the project The idea for